Zaldiar – Medicinal Product Register of Latvia

Tramadoli hydrochloridum, Paracetamolum

Search by the name of the active substance

Medicinal product name	Zaldiar 37.5 mg/325 mg film-coated tablets
Pharmaceutical form	Film-coated tablet
Strength	37.5 mg/325 mg
Information from the MAH on shortages	No information on expected shortages
Legal status	Rx Prescription (Pr.III)
Package leaflet	21-04-2022
Summary of product characteristics	21-04-2022
ATC code	N02AJ13 – Analgesics

Medicinal products (11)

Display only medicinal products with a declared price

Display only medicinal products available in wholesalers' stock

Availability of medicinal product	Wholesalers	Package size, content	Primary packaging	Maximum admissible pharmacy price (€ incl. VAT)	Product No.	Labelling
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N10 (37,5 mg/325 mg)	Paper/PET/Al/PVC blister	€ 4.54	04-0185-01	Labelling text Jun 18, 2020
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N2 (37,5 mg/325 mg)	Paper/PET/Al/PVC blister		04-0185-02	Labelling text Jun 18, 2020
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N20 (37,5 mg/325 mg)	Paper/PET/Al/PVC blister		04-0185-03	Labelling text Jun 18, 2020
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N30 (37,5 mg/325 mg)	Paper/PET/Al/PVC blister		04-0185-04	Labelling text Jun 18, 2020
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N40 (37,5 mg/325 mg)	Paper/PET/Al/PVC blister		04-0185-05	Labelling text Jun 18, 2020
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N50 (37,5 mg/325 mg)	Paper/PET/Al/PVC blister		04-0185-06	Labelling text Jun 18, 2020
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N60 (37,5 mg/325 mg)	Paper/PET/Al/PVC blister		04-0185-07	Labelling text Jun 18, 2020
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N70 (37,5 mg/325 mg)	Paper/PET/Al/PVC blister		04-0185-08	Labelling text Jun 18, 2020
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N80 (37,5 mg/325 mg)	Paper/PET/Al/PVC blister		04-0185-09	Labelling text Jun 18, 2020
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N90 (37,5 mg/325 mg)	Paper/PET/Al/PVC blister		04-0185-10	Labelling text Jun 18, 2020
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N100 (37,5 mg/325 mg)	Paper/PET/Al/PVC blister		04-0185-11	Labelling text Jun 18, 2020

Registration information

Marketing authorisation No.	04-0185
Date of authorisation	Apr 20, 2004
Marketing authorisation holder, country	Stada Arzneimittel AG, Germany

Return to the results

Icon explanation

– Medicine is available
– Medicine is not available
– Distribution permitted for a limited time span
– Without a prescription
– Prescription medicine

– Medicine is listed on the Latvian National Health Service (NHS) list of state reimbursed medicines. (source of the information – the NHS)
– Reference medicine on the NHS List of state reimbursed medicines
– Lowest cost medicine within its therapeutic effectiveness class in cases where no reference medicine is available
- – Next lowest cost medicine after or (in ascending order)

Class A A (green): Suitable for the older persons. The medicinal substance can be used as in younger patients. Changes due to aging do not affect the dose or frequency of administration, and the adverse reaction profile is not different from that of younger patients.

Class B B (grey): There is little research evidence, practical experience or efficacy in older persons.

Class C C (yellow): Suitable for older persons, with specific cautions. The medicinal substance can be used by older persons, but the dose might either have to be reduced, or the frequency of administration decreased due to mild or moderate renal insufficiency or a significant risk of interactions or adverse reactions.

Class D D (red): Avoid use in older persons. Use is possible only in exceptional cases or on a one-off basis. Changes due to aging predispose older persons to adverse or dangerous reactions to the drug. The risk of adverse reactions typically exceeds the benefits.

Meds75+ data source is Finnish Medicines Agency Fimea (licensed under CC BY 4.0).
Data updated on Apr 24, 2024.